- $49.83bn
- $72.27bn
- €93.72bn
- 81
- 97
- 54
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 69,881 | 43,987 | 76,575 | 132,512 | 93,717 |
Cost of Revenue | |||||
Gross Profit | 32,628 | 22,015 | 34,649 | 46,071 | 34,802 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 63,430 | 47,262 | 64,233 | 114,519 | 85,030 |
Operating Profit | 6,451 | -3,275 | 12,342 | 17,993 | 8,687 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,746 | -5,978 | 10,685 | 22,049 | 10,228 |
Provision for Income Taxes | |||||
Net Income After Taxes | 155 | -8,628 | 5,840 | 13,961 | 4,860 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 148 | -8,635 | 5,821 | 13,887 | 4,771 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 148 | -8,635 | 5,821 | 13,887 | 4,771 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.495 | -1.54 | 1.86 | 4.23 | 1.62 |
Dividends per Share |